中国卫生标准管理
中國衛生標準管理
중국위생표준관리
China Health Standard Management
2015年
27期
87-88
,共2页
盐酸氨溴索%哌拉西林/舒巴坦%肺部感染%2型糖尿病%治疗
鹽痠氨溴索%哌拉西林/舒巴坦%肺部感染%2型糖尿病%治療
염산안추색%고랍서림/서파탄%폐부감염%2형당뇨병%치료
Ambroxol hydrochloride%Piperacillin/shu ba jotham%Lung infection%Type 2 diabetes%Treatment
目的 对应用盐酸氨溴索与哌拉西林/舒巴坦联合对合并出现肺部感染的2型糖尿病患者实施治疗的临床效果进行研究.方法 抽取我院收治的82例合并出现肺部感染的2型糖尿病患者,随机分为对照组和治疗组,平均每组41例.采用盐酸溴己新与哌拉西林/舒巴坦联合对对照组实施治疗;采用盐酸氨溴索与哌拉西林/舒巴坦联合对治疗组实施治疗.结果 治疗组患者咳嗽发热等部分感染症状消失时间和糖尿病并肺部感染治疗计划实施总时间短于对照组;治疗组2型糖尿病合并肺部感染疾病的药物治疗效果优于对照组.结论 应用盐酸氨溴索与哌拉西林/舒巴坦联合对合并出现肺部感染的2型糖尿病患者实施治疗的临床效果优良.
目的 對應用鹽痠氨溴索與哌拉西林/舒巴坦聯閤對閤併齣現肺部感染的2型糖尿病患者實施治療的臨床效果進行研究.方法 抽取我院收治的82例閤併齣現肺部感染的2型糖尿病患者,隨機分為對照組和治療組,平均每組41例.採用鹽痠溴己新與哌拉西林/舒巴坦聯閤對對照組實施治療;採用鹽痠氨溴索與哌拉西林/舒巴坦聯閤對治療組實施治療.結果 治療組患者咳嗽髮熱等部分感染癥狀消失時間和糖尿病併肺部感染治療計劃實施總時間短于對照組;治療組2型糖尿病閤併肺部感染疾病的藥物治療效果優于對照組.結論 應用鹽痠氨溴索與哌拉西林/舒巴坦聯閤對閤併齣現肺部感染的2型糖尿病患者實施治療的臨床效果優良.
목적 대응용염산안추색여고랍서림/서파탄연합대합병출현폐부감염적2형당뇨병환자실시치료적림상효과진행연구.방법 추취아원수치적82례합병출현폐부감염적2형당뇨병환자,수궤분위대조조화치료조,평균매조41례.채용염산추기신여고랍서림/서파탄연합대대조조실시치료;채용염산안추색여고랍서림/서파탄연합대치료조실시치료.결과 치료조환자해수발열등부분감염증상소실시간화당뇨병병폐부감염치료계화실시총시간단우대조조;치료조2형당뇨병합병폐부감염질병적약물치료효과우우대조조.결론 응용염산안추색여고랍서림/서파탄연합대합병출현폐부감염적2형당뇨병환자실시치료적림상효과우량.
Objective The ambroxol hydrochloride and piperacillin/shu ba jotham for combined treatment of type 2 diabetes mellitus and lung infection were analyzed.Methods 82 cases of merger pulmonary infection in patients with type 2 diabetes were randomly divided into control group and treatment group,41 cases in each group. Using ambroxol hydrochloride and piperacillin/shu ba jotham for joint treatment. For control group,using ambroxol hydrochloride and piperacillin/ shu ba jotham for treatment.Results The treatment group patients with cough fever such as infection symptoms disappear time and lung infection and diabetes treatment plan to implement the total time were shorter than thecontrol group. Treatment group with pulmonary infection disease in type 2 diabetes, drug treatment effect was better than the control group. Conclusion Application of ambroxol hydrochloride and piperacillin/shu ba jotham joint of merger in pulmonary infection in patients with type 2 diabetes treatment,the clinical effect is fine.
